Weighted Average Number of Shares Outstanding, Basic of Vir Biotechnology, Inc. from 2019 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Vir Biotechnology, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from 2019 to Q3 2025.
  • Vir Biotechnology, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2025 was 139M shares, a 1.67% increase year-over-year.
  • Vir Biotechnology, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 136M shares, a 1.58% increase from 2023.
  • Vir Biotechnology, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 134M shares, a 1.15% increase from 2022.
  • Vir Biotechnology, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 133M shares, a 2.1% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Growth (%)

Vir Biotechnology, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 139M +2.28M +1.67% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-05
Q2 2025 138M +2.22M +1.63% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-06
Q1 2025 137M +2.19M +1.62% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-08
Q4 2024 136M +2.12M +1.58% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-27
Q3 2024 137M +2.36M +1.76% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-05
Q2 2024 136M +2.16M +1.62% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-06
Q1 2024 135M +1.73M +1.29% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-08
Q4 2023 134M +1.52M +1.15% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-27
Q3 2023 134M +1.56M +1.18% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-04
Q2 2023 134M +1.61M +1.22% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 134M +1.47M +1.12% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-03
Q4 2022 133M +2.72M +2.1% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-27
Q3 2022 133M +2.06M +1.58% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 132M +2.33M +1.79% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 132M +4.34M +3.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 130M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-26
Q3 2021 131M +4.85M +3.86% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 130M +15.1M +13.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 128M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q3 2020 126M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 115M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05

Vir Biotechnology, Inc. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 136M +2.12M +1.58% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-27
2023 134M +1.52M +1.15% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-27
2022 133M +2.72M +2.1% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-27
2021 130M +10.7M +9% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-26
2020 119M +88.8M +293% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 30.3M Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.